How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: a Multicenter Study
NCT ID: NCT06872632
Last Updated: 2025-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2326 participants
OBSERVATIONAL
2024-06-24
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For data collection, four index weeks will be identified during the year in which the participating Centers will have to sequentially enroll all the participants who will be admitted to the Internal Medicine units, until reaching, for each index week, 10 participants for each of the Participating Centers.
Each enrolled participant will undergo a 12-month follow-up. The study foresees the enrollment of 2326 participants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression
NCT05712967
A Multicenter Observational Cohort of Degenerative Spine Diseases in China(DSDC)
NCT05867732
Clinical and Biological Sample Database of Chinese Elderly Patients With Multiple Diseases
NCT05797402
Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.
NCT01903642
Osteomyelitis Multi-center Prospective Cohort Study
NCT07251374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Informed consent according to Italian law.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Società Italiana di Medicina Interna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOU Policlinico di Bari- Unità Operativa di Medicina Interna "Guido Baccelli
Bari, Italy, Italy
Azienda Ospedaliero Universitaria di Bologna Policlinico S. Orsola - Malpighi- UO Medicina interna, malattie epatobiliari e immunoallergologiche
Bologna, Italy, Italy
ASST degli Spedali Civili di Brescia- Medicina Generale 2
Brescia, Italy, Italy
Azienda Ospedaliero-Universitaria S. Anna di Ferrara- Clinica Medica
Ferrara, Italy, Italy
Ospedale Santa Maria Annunziata, Bagno a Ripoli, Firenze- Medicina 1
Florence, Italy, Italy
AOU G. Martino- UOC Medicina Interna
Messina, Italy, Italy
ASST Fatebenefratelli Sacco, Ospedale Luigi Sacco- Struttura Complessa di Medicina Interna
Milan, Italy, Italy
AOU Modena - Policlinico di Modena - S.C. Medicina Interna
Modena, Italy, Italy
Azienda Ospedaliera Universitaria Federico II, Napoli- UOC Medicina Interna ad indirizzo metabolico e riabilitativo
Napoli, Italy, Italy
Ospedale Maggiore della Carità di Novara- SCDU Medicina Interna 1, AOU Maggiore della Carità
Novara, Italy, Italy
Policlinico Universitario Campus Bio-Medico di Roma- UOC Medicina Interna
Roma, Italy, Italy
Azienda Ospedaliero-Universitaria Sant'Andrea- UOC Medicina Interna
Roma, Italy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
207/2023/OSS/AOUMO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.